#Canada #Vancouver #Eshbal #Gluten Free Nation #Dare To Be Different Foods

Eshbal Functional Food Inc. Projects Estimated Record Revenues for Q1 2026

Eshbal Functional Food Inc. (TSXV: ESBL), a publicly traded company based in Vancouver, has reported strong preliminary revenue figures for the first quarter ended March 31, 2026. The company estimates its revenues for this period to be around USD $5.3 million, which marks a substantial increase from USD $3.755 million in the same quarter of the previous year. This growth can be attributed to recent acquisitions that have reinforced Eshbal's operational framework and market reach.

Strategic Growth through Acquisitions

Tomer Bar-Meir, CEO of Eshbal, highlighted that the remarkable growth in revenue reflects the company’s ongoing strategic efforts, particularly the integration of two gluten-free brands: Dare to Be Different Foods and Gluten Free Nation. Both brands were acquired in mid-February 2026, which not only expanded Eshbal's product offerings but also enhanced its distribution capabilities across North America.

Eshbal Functional Foods has been keenly focused on building a scalable platform for health-oriented food brands. Since its listing on the TSX Venture Exchange in 2025, Eshbal has pursued a disciplined roll-up strategy aimed at acquiring both established and emerging brands that prioritize better-for-you options. The company integrates its acquisitions into a centralized operating platform designed to enhance operational efficiency and support margin expansion.

Significant Milestones Achieved

Some of the key operational milestones achieved by Eshbal include establishing robust brokerage representation in the U.S. to facilitate broader retail distribution, launching localized production in collaboration with Queen Street Bakery, and successfully acquiring majority interests in Gluten Free Nation and Dare to Be Different Foods. These achievements have significantly bolstered Eshbal's product line while optimizing its operational footprint and generating immediate incremental revenue.

The estimated revenue figures disclosed are preliminary and subject to modifications as they are finalized upon the completion of quarter-end financial procedures. Eshbal is expected to release its year-end 2025 results, along with Q4 2025 figures, in late April 2026, offering a more comprehensive look at the company's financial health and growth trajectory.

Looking Ahead

The forward-looking statements made by Eshbal should be understood with caution as they are based on management's current expectations and beliefs, which may evolve. The company is committed to transparency regarding its operational progress and financial performance, engaging actively with investors through its official website and social media channels.

Eshbal’s focus on gluten-free and health-centric food products aligns with growing consumer trends favoring nutritious and dietary-specific options. As they continue to refine their brand strategy and enhance their market presence, stakeholders and consumers alike will be watching to see how Eshbal leverages its strategic acquisitions for sustained growth and profitability in the upcoming quarters.

For more information, please visit Eshbal's official website or follow them on social media platforms for updates on their product lines and operational milestones.